This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

bleeding (postpartum haemorrhage)

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

This is bleeding from the genital tract after the delivery of a baby.

It can be broadly divided into primary and secondary types, the distinction being the timing of the onset of the bleed relative to the delivery.

A primary postpartum haemorrhage is a loss (usually defined as more than 500ml) in the first 24 hours after delivery.

It is important to note that in pregnancy the clinical parameters may be unreliable; for example, apparent normotension can be due to pre-eclampsia combined with blood loss.

Risk factors for postpartum haemorrhage

  • women with risk factors for postpartum haemorrhage should be advised to give birth in an obstetric unit where more emergency treatment options are available.
    • antenatal risk factors:
      • previous retained placenta or postpartum haemorrhage
      • maternal haemoglobin level below 8.5 g/dl at onset of labour
      • body mass index greater than 35 kg/m2
      • grand multiparity (parity 4 or more)
      • antepartum haemorrhage
      • overdistention of the uterus (for example, multiple pregnancy, polyhydramnios or macrosomia)
      • existing uterine abnormalities e.g fibroids
      • low-lying placenta
      • maternal age (35 years or older)
    • risk factors in labour:
      • induction
      • prolonged first, second or third stage of labour
      • oxytocin use
      • precipitate labour
      • operative birth or caesarean section.

Prevention of postpartum haemorrhage (2):

  • traditionally, oxytocin and ergot preparations have been used as uterotonic agents for postpartum haemorrhage prophylaxis mostly as part of active management of the third stage of labour
    • a major disadvantage, mainly related to ergot preparations, is the relatively high incidence of side-effects such as nausea, vomiting and increase in blood pressure
  • misoprostol may prevent severe postpartum haemorrhage but the evidence is inconsistent
    • misoprostol or intramuscular postaglandins are not more effective than conventional injectable uterotonics - both lead to more adverse effects
    • the review concludes that neither intramuscular prostaglandins nor misoprostol are preferable to conventional injectable uterotonics as part of the management of the third stage of labour especially for low-risk women.



The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.